A few other studies have pointed out that PAR1 overexpression alone may not lead to aggressive tumor phenotypes, and may be dependent on other pathways like Rho-mediated signaling [58] and Wnt-mediated β-catenin stabilization [59]. The gene discussed is F2R; the disease is neoplasm.